Proton-density fat fraction measurement: A viable quantitative biomarker for differentiating adrenal adenomas from nonadenomas.
暂无分享,去创建一个
Xiaoyan Meng | Yaqi Shen | Daoyu Hu | I. Kamel | Ihab R Kamel | D. Hu | Zhen Li | Hao Tang | Zhen Li | Xuemei Hu | Xiao Chen | Xuemei Hu | Hao Tang | Yaqi Shen | Xiaoyan Meng | X. Chen
[1] Scott B Reeder,et al. Quantification of liver fat with magnetic resonance imaging. , 2010, Magnetic resonance imaging clinics of North America.
[2] G. Gazelle,et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. , 1998, AJR. American journal of roentgenology.
[3] A. Gamst,et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. , 2009, Radiology.
[4] Jiang Shi,et al. Dual-energy CT: clinical application in differentiating an adrenal adenoma from a metastasis , 2014, Acta radiologica.
[5] A. Gamst,et al. Inter‐examination precision of magnitude‐based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects , 2014, Journal of magnetic resonance imaging : JMRI.
[6] Tosiaki Miyati,et al. Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T2 correction: phantom and clinical study with histologic assessment , 2012, Radiological Physics and Technology.
[7] Namkug Kim,et al. Hepatic Fat Quantification: A Prospective Comparison of Magnetic Resonance Spectroscopy and Analysis Methods for Chemical-Shift Gradient Echo Magnetic Resonance Imaging With Histologic Assessment as the Reference Standard , 2012, Investigative radiology.
[8] Scott B Reeder,et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. , 2011, Radiology.
[9] Giles W Boland,et al. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. , 2003, AJR. American journal of roentgenology.
[10] E. Siegelman. Adrenal MRI: Techniques and clinical applications , 2012, Journal of magnetic resonance imaging : JMRI.
[11] K. Ohtomo,et al. Differentiation of adrenal tumors in patients with hepatocellular carcinoma: adrenal adenoma versus metastasis. , 2013, European journal of radiology.
[12] D. DeLong,et al. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. , 2008, Radiology.
[13] I. Francis,et al. Adrenal imaging. , 1995, Seminars in ultrasound, CT, and MR.
[14] Berthold Kiefer,et al. Liver fat quantification using a multi‐step adaptive fitting approach with multi‐echo GRE imaging , 2014, Magnetic resonance in medicine.
[15] C. Kim,et al. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. , 2007, Radiology.
[16] R. Idilman,et al. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease , 2014, Scandinavian journal of gastroenterology.
[17] William W Mayo-Smith,et al. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. , 2008, Radiology.
[18] Hai-yan Qin,et al. Application of CT perfusion imaging to the histological differentiation of adrenal gland tumors. , 2012, European journal of radiology.
[19] Jang Ho Yoon,et al. The washout rate on the delayed CT image as a diagnostic tool for adrenal adenoma verified by pathology: a multicenter study , 2012, International Urology and Nephrology.
[20] R. Sebro,et al. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT , 2014, Abdominal Imaging.
[21] A. Gamst,et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.
[22] R. Idilman,et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. , 2013, Radiology.
[23] X. Xiao,et al. Diagnosis and treatment of adrenal tumours: a review of 35 years' experience. , 1998, British journal of urology.
[24] E. Merkle,et al. Effectiveness of a three-dimensional dual gradient echo two-point Dixon technique for the characterization of adrenal lesions at 3 Tesla , 2011, European Radiology.
[25] G. Low,et al. Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging. , 2013, AJR. American journal of roentgenology.
[26] R. Laqua,et al. Proton-density fat fraction and simultaneous R2* estimation as an MRI tool for assessment of osteoporosis , 2013, European Radiology.
[27] Lin Yang,et al. Abdominal MRI at 3.0 T: LAVA‐flex compared with conventional fat suppression T1‐weighted images , 2014, Journal of magnetic resonance imaging : JMRI.
[28] S. Reeder,et al. Quantification of hepatic steatosis with MRI: The effects of accurate fat spectral modeling , 2009, Journal of magnetic resonance imaging : JMRI.
[29] I. Francis,et al. Delayed enhanced CT of lipid-poor adrenal adenomas. , 2000, AJR. American journal of roentgenology.
[30] B. K. Park,et al. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. , 2014, AJR. American journal of roentgenology.
[31] R. Semelka,et al. Combined chemical shift imaging with early dynamic serial gadolinium-enhanced MRI in the characterization of adrenal lesions. , 2014, AJR. American journal of roentgenology.
[32] G. Scagliotti,et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series , 2006, Journal of endocrinological investigation.
[33] B. K. Park,et al. Adenoma characterization: adrenal protocol with dual-energy CT. , 2013, Radiology.
[34] S. Reeder,et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.